Published in Hum Reprod on December 01, 2002
Effects of recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-agonist protocol: a matched case-control study. Reprod Biol Endocrinol (2009) 0.95
Recombinant luteinizing hormone supplementation to recombinant follicle-stimulation hormone during induced ovarian stimulation in the GnRH-agonist protocol: a meta-analysis. J Assist Reprod Genet (2006) 0.86
Follicular fluid hormonal profile and cumulus cell gene expression in controlled ovarian hyperstimulation with recombinant FSH: effects of recombinant LH administration. J Assist Reprod Genet (2012) 0.83
Efficacy of low-dose human chorionic gonadotropin (hCG) in a GnRH antagonist protocol. J Assist Reprod Genet (2006) 0.81
Effects of LH on oocyte yield and developmental competence. Hum Reprod (2003) 0.78
Discontinuation of rLH two days before hCG may increase the number of oocytes retrieved in IVF. Reprod Biol Endocrinol (2010) 0.77
Efficient treatment of infertility due to sperm DNA damage by ICSI with testicular spermatozoa. Hum Reprod (2004) 2.42
Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles. Hum Reprod (2006) 1.78
Enhancement of embryo developmental potential by a single administration of GnRH agonist at the time of implantation. Hum Reprod (2004) 1.60
Late, but not early, paternal effect on human embryo development is related to sperm DNA fragmentation. Hum Reprod (2004) 1.38
Luteinizing hormone affects uterine receptivity independently of ovarian function. Reprod Biomed Online (2003) 1.11
Paternal effects acting during the first cell cycle of human preimplantation development after ICSI. Hum Reprod (2002) 1.06
Improvement of delivery and live birth rates after ICSI in women aged >40 years by ovarian co-stimulation with growth hormone. Hum Reprod (2005) 0.94
Apoptosis and necrosis in human ejaculated spermatozoa. Hum Reprod (2004) 0.94
Use of a modified intracytoplasmic sperm injection technique to overcome sperm-borne and oocyte-borne oocyte activation failures. Fertil Steril (2002) 0.91
IL-10 modulates serotonin transporter activity and molecular expression in intestinal epithelial cells. Cytokine (2013) 0.85
Caspase-dependent and -independent DNA fragmentation in Sertoli and germ cells from men with primary testicular failure: relationship with histological diagnosis. Hum Reprod (2004) 0.83
Sperm nuclear DNA damage: update on the mechanism, diagnosis and treatment. Reprod Biomed Online (2006) 0.82
Treatment of severe male infertility by micromanipulation-assisted fertilization: an update. Front Biosci (2007) 0.81
TLR2, TLR3, and TLR4 activation specifically alters the oxidative status of intestinal epithelial cells. Cell Stress Chaperones (2013) 0.81
In-vitro effects of FSH and testosterone withdrawal on caspase activation and DNA fragmentation in different cell types of human seminiferous epithelium. Hum Reprod (2002) 0.81
Caspase activity in preimplantation human embryos is not associated with apoptosis. Hum Reprod (2002) 0.78
Microfilament disruption is required for enucleation and nuclear transfer in germinal vesicle but not metaphase II human oocytes. Fertil Steril (2003) 0.77
Using the male gamete for assisted reproduction: past, present, and future. J Androl (2003) 0.76
Pharmacological concentrations of follicle-stimulating hormone and testosterone improve the efficacy of in vitro germ cell differentiation in men with maturation arrest. Fertil Steril (2002) 0.76
Melatonin inhibits serotonin transporter activity in intestinal epithelial cells. J Pineal Res (2010) 0.76
Somatic cell haploidization: an update. Reprod Biomed Online (2003) 0.75